Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records.

Lentine KL, Koraishy FM, Sarabu N, Naik AS, Lam NN, Garg AX, Axelrod D, Zhang Z, Hess GP, Kasiske BL, Segev DL, Henderson ML, Massie AB, Holscher CM, Schnitzler MA.

Clin Transplant. 2019 Aug 17:e13696. doi: 10.1111/ctr.13696. [Epub ahead of print]

PMID:
31421057
2.

National Variation in Increased Infectious Risk Kidney Offer Acceptance.

Holscher CM, Bowring MG, Haugen CE, Zhou S, Massie AB, Gentry SE, Segev DL, Garonzik Wang JM.

Transplantation. 2019 Feb 21. doi: 10.1097/TP.0000000000002631. [Epub ahead of print]

PMID:
31343577
3.

Association between Living Kidney Donor Post-Donation Hypertension and Recipient Graft Failure.

Holscher CM, Ishaque T, Haugen CE, Jackson KR, Garonzik Wang JM, Yu Y, Al Ammary F, Segev DL, Massie AB.

Transplantation. 2019 Jul 15. doi: 10.1097/TP.0000000000002832. [Epub ahead of print]

PMID:
31335778
4.

Predicting chance of liver transplantation for pediatric wait-list candidates.

Luo X, Mogul DB, Massie AB, Ishaque T, Bridges JFP, Segev DL.

Pediatr Transplant. 2019 Jul 16:e13542. doi: 10.1111/petr.13542. [Epub ahead of print]

PMID:
31313464
5.

Risk of ESKD in Older Live Kidney Donors with Hypertension.

Al Ammary F, Luo X, Muzaale AD, Massie AB, Crews DC, Waldram MM, Qadi MA, Garonzik-Wang J, Henderson ML, Brennan DC, Wiseman AC, Lindrooth RC, Snyder JJ, Coresh J, Segev DL.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1048-1055. doi: 10.2215/CJN.14031118. Epub 2019 Jun 25.

PMID:
31239252
6.

Barriers to access in pediatric living-donor liver transplantation.

Mogul DB, Lee J, Purnell TS, Massie AB, Ishaque T, Segev DL, Bridges JFP.

Pediatr Transplant. 2019 Sep;23(6):e13513. doi: 10.1111/petr.13513. Epub 2019 Jun 19.

PMID:
31215155
7.

Perspectives on implementing mobile health technology for living kidney donor follow-up: In-depth interviews with transplant providers.

Eno AK, Ruck JM, Van Pilsum Rasmussen SE, Waldram MM, Thomas AG, Purnell TS, Garonzik Wang JM, Massie AB, Al Almmary F, Cooper LM, Segev DL, Levan MA, Henderson ML.

Clin Transplant. 2019 Aug;33(8):e13637. doi: 10.1111/ctr.13637. Epub 2019 Jul 1.

PMID:
31194892
8.

Obesity and long-term mortality risk among living kidney donors.

Locke JE, Reed RD, Massie AB, MacLennan PA, Sawinski D, Kumar V, Snyder JJ, Carter AJ, Shelton BA, Mustian MN, Lewis CE, Segev DL.

Surgery. 2019 Aug;166(2):205-208. doi: 10.1016/j.surg.2019.03.016. Epub 2019 May 7.

PMID:
31072668
9.

Pediatric deceased donor kidney transplant outcomes under the kidney allocation system.

Jackson KR, Zhou S, Ruck J, Massie AB, Holscher C, Kernodle A, Glorioso J, Motter J, Neu A, Desai N, Segev DL, Garonzik-Wang J.

Am J Transplant. 2019 May 7. doi: 10.1111/ajt.15419. [Epub ahead of print]

PMID:
31062464
10.

The changing landscape of live kidney donation in the United States from 2005 to 2017.

Al Ammary F, Bowring MG, Massie AB, Yu S, Waldram MM, Garonzik-Wang J, Thomas AG, Holscher CM, Qadi MA, Henderson ML, Wiseman AC, Gralla J, Brennan DC, Segev DL, Muzaale AD.

Am J Transplant. 2019 Sep;19(9):2614-2621. doi: 10.1111/ajt.15368. Epub 2019 May 3.

PMID:
30903733
11.

A donor risk index for graft loss in pediatric living donor kidney transplantation.

Wasik HL, Pruette CS, Ruebner RL, McAdams-DeMarco MA, Zhou S, Neu AM, Segev DL, Massie AB.

Am J Transplant. 2019 Mar 15. doi: 10.1111/ajt.15360. [Epub ahead of print]

PMID:
30875148
12.

Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States.

Bowring MG, Shaffer AA, Massie AB, Cameron A, Desai N, Sulkowski M, Garonzik-Wang J, Segev DL.

Am J Transplant. 2019 Aug;19(8):2329-2341. doi: 10.1111/ajt.15355. Epub 2019 Apr 9.

PMID:
30861279
13.

Geographic disparity in deceased-donor liver transplant rates following Share 35.

Bowring MG, Zhou S, Chow EKH, Massie AB, Segev DL, Gentry SE.

Transplantation. 2019 Feb 19. doi: 10.1097/TP.0000000000002643. [Epub ahead of print]

PMID:
30801545
14.

Outcomes After Declining Increased Infectious Risk Kidney Offers for Pediatric Candidates in the United States.

Bowring MG, Jackson KR, Wasik H, Neu A, Garonzik-Wang J, Durand C, Desai N, Massie AB, Segev DL.

Transplantation. 2019 Feb 12. doi: 10.1097/TP.0000000000002674. [Epub ahead of print]

PMID:
30801530
15.

Assessment of Trends in Transplantation of Liver Grafts From Older Donors and Outcomes in Recipients of Liver Grafts From Older Donors, 2003-2016.

Haugen CE, Holscher CM, Luo X, Bowring MG, Orandi BJ, Thomas AG, Garonzik-Wang J, Massie AB, Philosophe B, McAdams-DeMarco M, Segev DL.

JAMA Surg. 2019 May 1;154(5):441-449. doi: 10.1001/jamasurg.2018.5568.

PMID:
30758494
16.

The Impact of the mKidney mHealth System on Live Donor Follow-Up Compliance: Protocol for a Randomized Controlled Trial.

Henderson ML, Thomas AG, Eno AK, Waldram MM, Bannon J, Massie AB, Levan MA, Segev DL, Bingaman AW.

JMIR Res Protoc. 2019 Jan 15;8(1):e11000. doi: 10.2196/11000.

17.

Offspring living kidney donors should not be ruled out.

Holscher CM, Luo X, Massie AB, Segev DL.

Am J Transplant. 2019 May;19(5):1595-1596. doi: 10.1111/ajt.15264. Epub 2019 Feb 7. No abstract available.

PMID:
30653826
18.

The landscape of international living kidney donation in the United States.

Al Ammary F, Thomas AG, Massie AB, Muzaale AD, Shaffer AA, Koons B, Qadi MA, Crews DC, Garonzik-Wang J, Fang H, Brennan DC, Lentine KL, Segev DL, Henderson ML.

Am J Transplant. 2019 Jul;19(7):2009-2019. doi: 10.1111/ajt.15256. Epub 2019 Feb 8.

PMID:
30615253
19.

Mitochondrial membrane potential and delayed graft function following kidney transplantation.

Garonzik-Wang JM, Lonze BE, Ruck JM, Luo X, Massie AB, Melancon K, Burdick JF, Segev DL, Sun Z.

Am J Transplant. 2019 Feb;19(2):585-590. doi: 10.1111/ajt.15174. Epub 2018 Dec 4.

PMID:
30408329
20.

Induction immunosuppression agents as risk factors for incident cardiovascular events and mortality after kidney transplantation.

Sandal S, Bae S, McAdams-DeMarco M, Massie AB, Lentine KL, Cantarovich M, Segev DL.

Am J Transplant. 2019 Apr;19(4):1150-1159. doi: 10.1111/ajt.15148. Epub 2018 Dec 6.

PMID:
30372596
21.

The national landscape of deceased donor kidney transplantation for the highly sensitized: Transplant rates, waitlist mortality, and posttransplant survival under KAS.

Jackson KR, Covarrubias K, Holscher CM, Luo X, Chen J, Massie AB, Desai N, Brennan DC, Segev DL, Garonzik-Wang J.

Am J Transplant. 2019 Apr;19(4):1129-1138. doi: 10.1111/ajt.15149. Epub 2018 Nov 26.

PMID:
30372592
22.

Liver transplantation and waitlist mortality for HCC and non-HCC candidates following the 2015 HCC exception policy change.

Ishaque T, Massie AB, Bowring MG, Haugen CE, Ruck JM, Halpern SE, Waldram MM, Henderson ML, Garonzik Wang JM, Cameron AM, Philosophe B, Ottmann S, Rositch AF, Segev DL.

Am J Transplant. 2019 Feb;19(2):564-572. doi: 10.1111/ajt.15144. Epub 2018 Nov 9.

PMID:
30312530
23.

Assessing the Attitudes and Perceptions Regarding the Use of Mobile Health Technologies for Living Kidney Donor Follow-Up: Survey Study.

Eno AK, Thomas AG, Ruck JM, Van Pilsum Rasmussen SE, Halpern SE, Waldram MM, Muzaale AD, Purnell TS, Massie AB, Garonzik Wang JM, Lentine KL, Segev DL, Henderson ML.

JMIR Mhealth Uhealth. 2018 Oct 9;6(10):e11192. doi: 10.2196/11192.

24.

Better graft outcomes from offspring donor kidneys among living donor kidney transplant recipients in the United States.

Holscher CM, Luo X, Massie AB, Purnell TS, Garonzik Wang JM, Bae S, Henderson ML, Al Ammary F, Ottman SE, Segev DL.

Am J Transplant. 2019 Jan;19(1):269-276. doi: 10.1111/ajt.15126. Epub 2018 Oct 16.

PMID:
30253051
25.

Early Hypertension and Diabetes After Living Kidney Donation: A National Cohort Study.

Holscher CM, Bae S, Thomas AG, Henderson ML, Haugen CE, DiBrito SR, Muzaale AD, Garonzik Wang JM, Massie AB, Lentine KL, Segev DL.

Transplantation. 2019 Jun;103(6):1216-1223. doi: 10.1097/TP.0000000000002411.

PMID:
30247449
26.

Expansion of the Liver Donor Supply Through Greater Use of Split-Liver Transplantation: Identifying Optimal Recipients.

Mogul DB, Luo X, Garonzik-Wang J, Bowring MG, Massie AB, Schwarz KB, Cameron AM, Bridges JFP, Segev DL.

Liver Transpl. 2019 Jan;25(1):119-127. doi: 10.1002/lt.25340.

PMID:
30230191
27.

Anxiety, depression, and regret of donation in living kidney donors.

Holscher CM, Leanza J, Thomas AG, Waldram MM, Haugen CE, Jackson KR, Bae S, Massie AB, Segev DL.

BMC Nephrol. 2018 Sep 4;19(1):218. doi: 10.1186/s12882-018-1024-0.

28.

Temporal Changes in the Impact of HLA Mismatching Among Pediatric Kidney Transplant Recipients.

Ruck JM, Jackson AM, Massie AB, Segev DL, Desai N, Garonzik-Wang J.

Transplantation. 2019 Jun;103(6):1267-1271. doi: 10.1097/TP.0000000000002426.

PMID:
30130329
29.

Living donor postnephrectomy kidney function and recipient graft loss: A dose-response relationship.

Holscher CM, Ishaque T, Garonzik Wang JM, Haugen CE, DiBrito SR, Jackson KR, Muzaale AD, Massie AB, Al Ammary F, Ottman SE, Henderson ML, Segev DL.

Am J Transplant. 2018 Nov;18(11):2804-2810. doi: 10.1111/ajt.15061. Epub 2018 Aug 31.

PMID:
30086198
30.

Temporal changes in the composition of a large multicenter kidney exchange clearinghouse: Do the hard-to-match accumulate?

Holscher CM, Jackson K, Thomas AG, Haugen CE, DiBrito SR, Covarrubias K, Gentry SE, Ronin M, Waterman AD, Massie AB, Garonzik Wang J, Segev DL.

Am J Transplant. 2018 Nov;18(11):2791-2797. doi: 10.1111/ajt.15046. Epub 2018 Sep 12.

PMID:
30063811
31.

MELD allocation system: There is always space to improve.

Luo X, Massie AB, Gentry SE, Segev DL.

Am J Transplant. 2018 Nov;18(11):2834-2835. doi: 10.1111/ajt.15036. Epub 2018 Aug 13. No abstract available.

PMID:
30052316
32.

Prospective Validation of Prediction Model for Kidney Discard.

Zhou S, Massie AB, Holscher CM, Waldram MM, Ishaque T, Thomas AG, Segev DL.

Transplantation. 2019 Apr;103(4):764-771. doi: 10.1097/TP.0000000000002362.

PMID:
30015701
33.

Landscape of Living Multiorgan Donation in the United States: A Registry-Based Cohort Study.

Henderson ML, DiBrito SR, Thomas AG, Holscher CM, Shaffer AA, Bowring MG, Purnell TS, Massie AB, Garonzik-Wang JM, Waldram MM, Lentine KL, Segev DL.

Transplantation. 2018 Jul;102(7):1148-1155. doi: 10.1097/TP.0000000000002082.

34.

Organs from deceased donors with false-positive HIV screening tests: An unexpected benefit of the HOPE act.

Durand CM, Halpern SE, Bowring MG, Bismut GA, Kusemiju OT, Doby B, Fernandez RE, Kirby CS, Ostrander D, Stock PG, Mehta S, Turgeon NA, Wojciechowski D, Huprikar S, Florman S, Ottmann S, Desai NM, Cameron A, Massie AB, Tobian AAR, Redd AD, Segev DL.

Am J Transplant. 2018 Oct;18(10):2579-2586. doi: 10.1111/ajt.14993. Epub 2018 Jul 23.

PMID:
29947471
35.

Who can tolerate a marginal kidney? Predicting survival after deceased donor kidney transplant by donor-recipient combination.

Bae S, Massie AB, Thomas AG, Bahn G, Luo X, Jackson KR, Ottmann SE, Brennan DC, Desai NM, Coresh J, Segev DL, Garonzik Wang JM.

Am J Transplant. 2019 Feb;19(2):425-433. doi: 10.1111/ajt.14978. Epub 2018 Jul 14.

PMID:
29935051
36.

Consent and labeling in the use of infectious risk donor kidneys: A response to "Information Overload".

Bowring MG, Massie AB, Henderson M, Segev DL.

Am J Transplant. 2018 Oct;18(10):2608-2609. doi: 10.1111/ajt.14975. Epub 2018 Jul 2. No abstract available.

PMID:
29920936
37.

Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy.

Bowring MG, Kucirka LM, Massie AB, Ishaque T, Bae S, Shaffer AA, Garonzik Wang J, Sulkowski M, Desai N, Segev DL, Durand CM.

Transplantation. 2018 Dec;102(12):2088-2095. doi: 10.1097/TP.0000000000002323.

PMID:
29912046
38.

Interviews of living kidney donors to assess donation-related concerns and information-gathering practices.

Ruck JM, Van Pilsum Rasmussen SE, Henderson ML, Massie AB, Segev DL.

BMC Nephrol. 2018 Jun 8;19(1):130. doi: 10.1186/s12882-018-0935-0.

39.

Racial differences in completion of the living kidney donor evaluation process.

Kumar K, Tonascia JM, Muzaale AD, Purnell TS, Ottmann SE, Al Ammary F, Bowring MG, Poon A, King EA, Massie AB, Chow EKH, Thomas AG, Ying H, Borja M, Konel JM, Henderson M, Cameron AM, Garonzik-Wang JM, Segev DL.

Clin Transplant. 2018 Jul;32(7):e13291. doi: 10.1111/ctr.13291. Epub 2018 Jun 15.

40.

Willingness to Donate Organs Among People Living With HIV.

Nguyen AQ, Anjum SK, Halpern SE, Kumar K, Van Pilsum Rasmussen SE, Doby B, Shaffer AA, Massie AB, Tobian AAR, Segev DL, Sugarman J, Durand CM.

J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):e30-e36. doi: 10.1097/QAI.0000000000001760.

41.

Kidney offer acceptance at programs undergoing a Systems Improvement Agreement.

Bowring MG, Massie AB, Craig-Schapiro R, Segev DL, Nicholas LH.

Am J Transplant. 2018 Sep;18(9):2182-2188. doi: 10.1111/ajt.14907. Epub 2018 Jun 4.

42.

The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States: A National Registry Study.

Durand CM, Bowring MG, Thomas AG, Kucirka LM, Massie AB, Cameron A, Desai NM, Sulkowski M, Segev DL.

Ann Intern Med. 2018 May 15;168(10):702-711. doi: 10.7326/M17-2451. Epub 2018 Apr 17.

43.

Correlation Between Kidney Transplant Outcome Metrics and Waitlist Metrics.

Zhou S, Holscher CM, Massie AB, Segev DL, Nicholas LH.

Transplantation. 2018 Aug;102(8):e362-e363. doi: 10.1097/TP.0000000000002254. No abstract available.

44.

Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study.

Haugen CE, Thomas AG, Garonzik-Wang J, Massie AB, Segev DL.

Transplantation. 2018 Sep;102(9):1514-1519. doi: 10.1097/TP.0000000000002190.

45.

Machine perfusion and long-term kidney transplant recipient outcomes across allograft risk strata.

Sandal S, Luo X, Massie AB, Paraskevas S, Cantarovich M, Segev DL.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1251-1259. doi: 10.1093/ndt/gfy010.

46.

Kidney exchange match rates in a large multicenter clearinghouse.

Holscher CM, Jackson K, Chow EKH, Thomas AG, Haugen CE, DiBrito SR, Purcell C, Ronin M, Waterman AD, Garonzik Wang J, Massie AB, Gentry SE, Segev DL.

Am J Transplant. 2018 Jun;18(6):1510-1517. doi: 10.1111/ajt.14689. Epub 2018 Mar 9.

47.

The Authors' Reply.

Massie AB, Roberts JP.

Transplantation. 2018 May;102(5):e250-e251. doi: 10.1097/TP.0000000000002109. No abstract available.

PMID:
29346261
48.

MELD as a metric for survival benefit of liver transplantation.

Luo X, Leanza J, Massie AB, Garonzik-Wang JM, Haugen CE, Gentry SE, Ottmann SE, Segev DL.

Am J Transplant. 2018 May;18(5):1231-1237. doi: 10.1111/ajt.14660. Epub 2018 Feb 19.

49.

Fifteen-Year Trends in Pediatric Liver Transplants: Split, Whole Deceased, and Living Donor Grafts.

Mogul DB, Luo X, Bowring MG, Chow EK, Massie AB, Schwarz KB, Cameron AM, Bridges JFP, Segev DL.

J Pediatr. 2018 May;196:148-153.e2. doi: 10.1016/j.jpeds.2017.11.015. Epub 2018 Jan 4.

50.

Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014.

Purnell TS, Luo X, Cooper LA, Massie AB, Kucirka LM, Henderson ML, Gordon EJ, Crews DC, Boulware LE, Segev DL.

JAMA. 2018 Jan 2;319(1):49-61. doi: 10.1001/jama.2017.19152.

Supplemental Content

Loading ...
Support Center